Trials to test the efficacy of the Gilead drug remdesivir to treat COVID-19 are running ahead of schedule and could be completed as early as mid-May, says the lead investigator on the project.
US-based doctors have been rushing to enroll patients in the trial after anecdotal evidence showed the drug might be effective at treating the novel coronavirus, study chief Dr. Andre Kalil told Reuters.
Houston Methodist Hospital has treated 41 coronavirus patients with the drugs, with many later being sent home are symptoms subsided.
Remdesivir is one of many experimental drugs, which researchers are testing in the hopes that it might prove effective against COVID-19. Several critically ill patients in New York City were able to be taken off ventilators after treatment with another drug, leronlimab.
There is currently no vaccine or FDA-approved treatment for the deadly virus which has now killed more than 50,000 people in the United States.
Source: NY POST